EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma

Tingchen Mou, Haoran Zhu, Yanbo Jiang, Xuhui Xu, Lina Cai, Yuan Zhong, Jun Luo, Zhenxing Zhang

Translational Oncology · 2023-09 · 35 · 101717

DOI: 10.1016/j.tranon.2023.101717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2023-09. Verfasst von Tingchen Mou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of stomatology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou 318000, Zhejiang Province, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer-associated fibroblasts (CAFs) consist of heterogeneous cellular populations that contribute critical roles in head and neck squamous cell carcinoma (HNSCC). A series of computer-aided analyses were performed to determine various aspects of CAFs in HNSCC, including their cellular heterogeneity, prognostic value, relationship with immune suppression and immunotherapeutic response, intercellular communication, and metabolic activity. The prognostic significance of CKS2+ CAFs was verified using immunohistochemistry. Our findings revealed that fibroblasts group demonstrated prognostic significance, with the CKS2+ subset of inflammatory CAFs (iCAFs) exhibiting a significant correlation with unfavorable prognosis and being localized in close proximity to cancer cells. Patients with a high infiltration of CKS2+ CAFs had a poor overall survival rate. There is a negative correlation between CKS2+ iCAFs and cytotoxic CD8+ T cells and natural killer (NK) cells, while a positive correlation was found with exhausted CD8+ T cells. Additionally, patients in Cluster 3, characterized by a high proportion of CKS2+ iCAFs, and patients in Cluster 2, characterized by a high proportion of CKS2- iCAFs and CENPF-/MYLPF- myofibroblastic CAFs (myCAFs), did not exhibit significant immunotherapeutic responses. Moreover, close interactions was confirmed to exist between cancer cells and CKS2+ iCAFs/ CENPF+ myCAFs. Furthermore, CKS2+ iCAFs demonstrated the highest level of metabolic activity. In summary, our study enhances the understanding of the heterogeneity of CAFs and provided insights into improving the efficacy of immunotherapies and prognostic accuracy for HNSCC patients.

Schlagwörter

Stichwörter der Autor:innen

Cancer associated fibroblastsHead and neck squamous cell carcinomaHeterogeneousSingle-cell RNA sequenceTumor microenvironment

Autor:innen und Institutionen

  • Department of stomatology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou 318000, Zhejiang Province, China.
  • Xi'an Jiaotong University Health Science Center, Xi'an 710000, Shaanxi Province, China.
  • Department of Maxillofacial Surgery, Liuzhou People's Hospital (Liuzhou People's Hospital affiliated to Guangxi Medical University), Liuzhou 545000, Guangxi Province, China.
  • Department of stomatology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou 318000, Zhejiang Province, China. Electronic address: zzx9467@tzc.edu.cn.

Zitieren

APA

Mou, T., Zhu, H., Jiang, Y., Xu, X., Cai, L., Zhong, Y., Luo, J., & Zhang, Z. (2023). Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Translational Oncology, 35, 101717. https://doi.org/10.1016/j.tranon.2023.101717

Vancouver

Mou T, Zhu H, Jiang Y, Xu X, Cai L, Zhong Y, et al. Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma. Translational Oncology. 2023;35:101717. doi:10.1016/j.tranon.2023.101717

BibTeX
@article{Mou2023,
  author = {Mou, Tingchen and Zhu, Haoran and Jiang, Yanbo and Xu, Xuhui and Cai, Lina and Zhong, Yuan and Luo, Jun and Zhang, Zhenxing},
  title = {Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma},
  journal = {Translational Oncology},
  year = {2023},
  volume = {35},
  pages = {101717},
  doi = {10.1016/j.tranon.2023.101717}
}
Kostenlos starten →